{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:40Z","timestamp":1772119480307,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10549-021-06465-4","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T05:06:51Z","timestamp":1638421611000},"page":"643-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Studying the association between breast cancer and renal cell carcinoma"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-4293","authenticated-orcid":false,"given":"Khalid","family":"Jazieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Baidoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataly","family":"Torrejon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahi","family":"Merjaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Gad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jame","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"6465_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2741\/4230","volume":"19","author":"A Paul","year":"2014","unstructured":"Paul A, Paul S (2014) The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) 19:605\u2013618","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6465_CR2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/cncr.21051","volume":"103","author":"RP Dikshit","year":"2005","unstructured":"Dikshit RP, Boffetta P, Bouchardy C, Merletti F, Crosignani P, Cuchi T et al (2005) Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 103:2326\u20132333. https:\/\/doi.org\/10.1002\/cncr.21051","journal-title":"Cancer"},{"key":"6465_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/02841869409121767","volume":"33","author":"P Boffetta","year":"1994","unstructured":"Boffetta P, Kaldor JM (1994) Secondary malignancies following cancer chemotherapy. Acta Oncol (Madr) 33:591\u2013598. https:\/\/doi.org\/10.3109\/02841869409121767","journal-title":"Acta Oncol (Madr)"},{"key":"6465_CR4","doi-asserted-by":"publisher","first-page":"XD03","DOI":"10.7860\/JCDR\/2016\/20362.8683","volume":"10","author":"R Arjunan","year":"2016","unstructured":"Arjunan R, Kumar D, Kumar KVV, Premlatha CS (2016) Breast cancer with synchronous renal cell carcinoma: a rare presentation. J Clin Diagn Res 10:XD03\u2013XD05. https:\/\/doi.org\/10.7860\/JCDR\/2016\/20362.8683","journal-title":"J Clin Diagn Res"},{"key":"6465_CR5","doi-asserted-by":"publisher","first-page":"6246209","DOI":"10.1155\/2019\/6246209","volume":"2019","author":"IY Sheng","year":"2019","unstructured":"Sheng IY, Kruse M, Leininger KM, Ornstein MC (2019) Tailoring immunotherapy treatment of synchronous renal cell carcinoma (RCC) and triple-negative breast cancer (TNBC). Case Rep Oncol Med 2019:6246209. https:\/\/doi.org\/10.1155\/2019\/6246209","journal-title":"Case Rep Oncol Med"},{"key":"6465_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12262-013-1031-0","volume":"77","author":"UA Kurlekar","year":"2015","unstructured":"Kurlekar UA, Rayate AS (2015) Synchronous primary malignancies in breast and kidney: a rare case report. Indian J Surg 77:6\u20139. https:\/\/doi.org\/10.1007\/s12262-013-1031-0","journal-title":"Indian J Surg"},{"key":"6465_CR7","doi-asserted-by":"publisher","unstructured":"Sidoun M, Elfageih M, Albolatti K, Elrgaig M, Eltruki A, Salah K et al (2021) Metachronous breast cancer in patient with renal cell cancer, experience at national cancer institute in misrata-libya. Int J Stem Cell Regen Med. https:\/\/doi.org\/10.36266\/IJSCRM\/110","DOI":"10.36266\/IJSCRM\/110"},{"key":"6465_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4236\/jct.2018.911075","volume":"09","author":"A Rayan","year":"2018","unstructured":"Rayan A, Ashraf AAM, Bakri HAM (2018) Multiple primary malignancies: metastatic renal with early breast and endometrial cancers: a case report. J Cancer Ther 09:907\u2013913. https:\/\/doi.org\/10.4236\/jct.2018.911075","journal-title":"J Cancer Ther"},{"key":"6465_CR9","doi-asserted-by":"publisher","DOI":"10.3332\/ECANCER.2020.1120","author":"MA Hassan","year":"2020","unstructured":"Hassan MA, Fakhrudiin N, Farhat F (2020) Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behaviour: a case report with a literature review. Ecancermedicalscience. https:\/\/doi.org\/10.3332\/ECANCER.2020.1120","journal-title":"Ecancermedicalscience"},{"key":"6465_CR10","volume-title":"Cancer facts & figures 2021","author":"American Cancer Society","year":"2021","unstructured":"American Cancer Society (2021) Cancer facts & figures 2021. American Cancer Society, Atlanta"},{"key":"6465_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1464-410X.2006.06004.x","volume":"97","author":"C Beisland","year":"2006","unstructured":"Beisland C, Talleraas O, Bakke A, Norstein J (2006) Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU Int 97:698\u2013702. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06004.x","journal-title":"BJU Int"},{"key":"6465_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4274\/uob.galenos.2020.1785","volume":"20","author":"H Demir","year":"2021","unstructured":"Demir H, Y\u00fclek \u00d6, Oru\u00e7 E, Gulle B, Demir D, Demirdag C et al (2021) Second primary malignant tumours in patients with renal cell carcinoma. Bull Urooncol 20:49\u201355. https:\/\/doi.org\/10.4274\/uob.galenos.2020.1785","journal-title":"Bull Urooncol"},{"key":"6465_CR13","unstructured":"Surveillance, epidemiology, and end results (SEER) Program (1969) SEER*Stat database: incidence\u2014SEER 18 regs custom data (with additional treatment fields), Nov 2016 Sub (1973\u20132014 varying)\u2014linked to county attributes\u2014total U.S. www.seer.cancer.gov"},{"key":"6465_CR14","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software, version 8.3.4. www.seer.cancer.gov\/seerstat"},{"key":"6465_CR15","unstructured":"IBM corp (2019) IBM SPSS statistics for windows, version 26.0. IBMcorp, Armonk"},{"key":"6465_CR16","unstructured":"R Development Core Team (2010) R: a language and environment for statistical computing"},{"key":"6465_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/J.EJCA.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/J.EJCA.2008.10.026","journal-title":"Eur J Cancer"},{"key":"6465_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS9122675","author":"L Stolarova","year":"2020","unstructured":"Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, Kleibl Z (2020) CHEK2 GERMLINE variants in cancer predisposition: stalemate rather than checkmate. Cells. https:\/\/doi.org\/10.3390\/CELLS9122675","journal-title":"Cells"},{"key":"6465_CR19","first-page":"179","volume":"99","author":"RE Gray","year":"2019","unstructured":"Gray RE, Harris GT (2019) Renal cell carcinoma: diagnosis and management. Am Fam Physician 99:179\u2013184","journal-title":"Am Fam Physician"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06465-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06465-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06465-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T09:05:40Z","timestamp":1644483940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06465-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6465"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06465-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-841536\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB approval was obtained via our institutional IRB review committee, and informed consent was waived as this was a retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}